Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the CDX-2 Test Immunohistochemistry is 7 days.

What are the prerequisites for the test CDX-2 Test Immunohistochemistry

Prerequisites for CDX-2 Test Immunohistochemistry

  • A formalin-fixed, paraffin-embedded tissue sample
  • Properly labeled slides with tissue sections
  • Appropriate antibodies for CDX-2 staining
  • Reagents for immunohistochemistry staining
  • Access to a microscope for analysis of staining results

What are the measure values for the test CDX-2 Test Immunohistochemistry

  • Positive: Nuclear staining in colorectal carcinoma cells
  • Negative: Absence of nuclear staining in colorectal carcinoma cells
  • Intensity: Weak, Moderate, Strong
  • Percentage of stained cells: < 5%, 5-50%, >50%

What does this test CDX-2 Test Immunohistochemistry identify?

The CDX-2 Test Immunohistochemistry is used to identify the presence of the CDX-2 protein in tissue samples. CDX-2 is a transcription factor that plays a crucial role in the development and maintenance of the intestinal epithelium. This test is commonly used in the diagnosis of colorectal cancer, as CDX-2 is typically expressed in normal intestinal epithelium but may be absent or reduced in colorectal cancer cells.

Why is this test CDX-2 Test Immunohistochemistry taken?

CDX-2 Test Immunohistochemistry

The CDX-2 test is a type of immunohistochemistry test that is used to detect the presence of the CDX-2 protein in cells. This test is commonly used in the diagnosis and management of gastrointestinal cancers, particularly colorectal cancer. CDX-2 is a transcription factor that plays a key role in the development and differentiation of intestinal cells. Abnormal expression of CDX-2 has been associated with various types of gastrointestinal cancers, making it a valuable marker for diagnosing and monitoring these diseases.

During the CDX-2 test, a tissue sample is collected from the patient and stained with antibodies that specifically target the CDX-2 protein. The presence and distribution of CDX-2 in the cells are then visualized under a microscope. Results of the test can help healthcare providers determine the type and stage of cancer, as well as guide treatment decisions. The CDX-2 test is often performed in conjunction with other diagnostic tests to provide a comprehensive evaluation of the patient's condition.

No FAQs available.

Customer Google Rating